Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc. (GWLL) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001800373 · GWLL · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001800373 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Goldenwell Biotech, Inc. (OTC: GWLL) has submitted 75 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Consumer Defensive sector company with CIK 0001800373, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Goldenwell Biotech, Inc.'s most comprehensive regulatory disclosure. The most recent Goldenwell Biotech, Inc. 10-K was filed on 2025-05-15 for fiscal year ending 2025. Historical GWLL 10-K annual reports are available from 2020 through 2025.
Investors researching Goldenwell Biotech, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
GWLL SEC Filings · 8 questionsGoldenwell Biotech, Inc. (GWLL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 75 filings and access original documents at no cost. Goldenwell Biotech, Inc.'s CIK is 0001800373.